Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2021 10:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that Jigar Raythatha, CEO, will present a company overview at the J.P....
December 06, 2020 08:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Provides Update of MANIFEST Study for CPI-0610 at ASH Meeting

67% spleen volume response rate observed in 63 first-line myelofibrosis patients treated with CPI-0610 + ruxolitinib at 24 weeksCPI-0610 demonstrated activity, both as a monotherapy and as add on to...
November 23, 2020 13:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Host Analyst / Investor Event to Discuss Update of MANIFEST Clinical Trial for CPI-0610 Presented at ASH Meeting

CAMBRIDGE, Mass., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and...
October 29, 2020 07:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Announces Third-Quarter 2020 Financial Results

MANIFEST data update planned for the American Society of Hematology (ASH) meeting in December CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a...
October 19, 2020 14:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2020 Results

CAMBRIDGE, Mass., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...
September 09, 2020 15:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to...
August 05, 2020 07:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update

Constellation has aligned with the FDA on the design of MANIFEST-2, the pivotal Phase 3 clinical trial for CPI-0610 expected to begin in 2H20Constellation plans to explore additional indications for...
July 31, 2020 12:00 ET | Source: Constellation Pharmaceuticals , Inc.

Constellation Pharmaceuticals to Host Conference Call to Discuss Second Quarter 2020 Results

CAMBRIDGE, Mass., July 31, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop...